Biomerieux, Kloeckner & Co, UniCredit: Europe Equity Preview

Shares of the following companies may have unusual moves in European (SXXP) trading. Stock symbols are in parentheses.

The Stoxx Europe 600 Index fell 0.4 percent to 256.04. The Stoxx 50 Index slipped 0.1 percent to 2,452.48. The Euro Stoxx 50 Index (SX5E), a benchmark measure for nations using the euro, declined 0.4 percent to 2,432.07.

Biomerieux SA (BIM) : The maker of tests for HIV and hepatitis said fourth-quarter revenue rose to 406.5 million euros, from 373.4 million euros a year earlier. The company also forecast 2012 like-for-like sales growth of between 3 percent and 5 percent. The shares rose 0.4 percent to 58.31 euros.

Deceuninck NV (DECB) : Europe’s third-largest maker of plastic window frames was raised to “hold” from “reduce” by Wim Hoste, an equity analyst at KBC Securities, with a share price estimate of 1.05 euros. Deceuninck fell 2.9 percent to 1.01 euros.

Hannover Rueckversicherung AG (HNR1) (HNR1 GY): The insurer was lowered to “neutral” from “buy” by Christian Muschick, an equity analyst at Silvia Quandt Research. The 18-month price estimate is 42.20 euros. The shares fell 1.2 percent to 40.33 euros.

Kloeckner & Co SE (KCO GY): The steel distributor was lowered to “hold” from “buy” by Matthias Pfeifenberger, an equity analyst at Deutsche Bank AG, with a 12-month price estimate of 13 euros. Kloeckner fell 2.9 percent to 11.76 euros.

Publicis Groupe (PUB) : France’s biggest advertising company said its “long-lasting” relationship with General Motors Co. has ended. The companies’ Starcom partnership accounted for less than 0.5 percent of the Paris-based company’s annual revenue, the company said. The shares fell 1.5 percent to 38.53 euros.

UniCredit SpA (UCG) : Capital Research & Management Co., a Los Angeles-based investment fund, increased its stake in Italy’s biggest bank, which is raising cash to plug a capital shortfall and comply with European (SXXP) rules. UniCredit rose 2.5 percent to 3.75 euros.

To contact the reporter on this story: Katia Porzecanski in New York at kporzecansk1@bloomberg.net

To contact the editor responsible for this story: Andrew Rummer at arummer@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.